Skip to main content
CLOV
NASDAQ Life Sciences

Clover Health Tops Q3 Estimates With $759M Revenue and $16M Adjusted EBITDA

Tom Rudovsky · Reported by Reuters
More coverage: Financial
Sentiment info
Positive
Importance info
8
Price
$4.71
Mkt Cap
$2.491B
52W Low
$1.58
52W High
$5.59
52W Position info
198% above low
Off High info
16% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

CLOV has more than doubled off its 52-week low of $1.58.

Summary

Clover Health beat on both lines in Q3: revenue of $759M came in above the $738.4M IBES estimate, and adjusted EBITDA of $16M nearly doubled the $9.31M consensus. Net income was $6M, a swing to profit versus the year-ago loss and a step down from Q2's $28.0M profit. The print follows a strong Q2 that showed membership up 49% and a $28.0M net profit, and an October CMS award of 5 Stars for the 2027 PPO Medicare Advantage plans, up from 4.5 Stars. Clover also raised its 2026 guidance, now calling for revenue of $2.97B-$3.00B, GAAP net income of $25M-$35M, gross profit of $540M-$555M, adjusted EBITDA of $75M-$85M and average MA membership of 157,000-158,000, and it expects its first full-year GAAP profit. Beating on revenue and EBITDA with positive net income supports the margin-improvement story the market has been paying for. Watch whether the Q2-to-Q3 net income decline reflects seasonality or rising medical costs when management details the quarter.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Clover raised 2026 guidance: revenue $2.97B-$3.00B, GAAP net income $25M-$35M, gross profit $540M-$555M, adjusted EBITDA $75M-$85M, average MA membership 157,000-158,000.

At the time of this announcement, CLOV was trading at $4.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $1.58 to $5.59. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CLOV - Latest Insights

CLOV
Nov 06, 2026, 8:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.45
Real-time Price: $3.71 info
Change: -$0.7402 (-17%) info
Market Cap: $1.976B info
CLOV
Nov 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.67
Real-time Price: $3.71 info
Change: -$0.960 (-21%) info
Market Cap: $1.976B info
CLOV
Oct 08, 2026, 6:45 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $3.71 info
Change: -$1.29 (-26%) info
Market Cap: $1.976B info
CLOV
Aug 07, 2026, 8:04 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.69
Real-time Price: $3.71 info
Change: -$0.980 (-21%) info
Market Cap: $1.976B info
CLOV
Jul 17, 2026, 5:49 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.61
Real-time Price: $3.71 info
Change: -$0.900 (-20%) info
Market Cap: $1.976B info